Get started
ACCESS BIO, INC.ACCESS BIO, INC.ACCESS BIO, INC.

ACCESS BIO, INC.

No trades
See on Supercharts
Overview
Financials Ideas Discussions Technicals Seasonals

950130 chart


Full chart

Key stats


Market capitalization
‪183.36 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−10 KRW
Net income (FY)
‪−347.50 M‬ KRW
Revenue (FY)
‪112.44 B‬ KRW
Shares float
‪28.50 M‬
Beta (1Y)
0.25

About ACCESS BIO, INC.


Sector
Health Technology
Industry
Medical Specialties
CEO
Young-Ho Choi
Website
accessbio.net
Headquarters
Somerset
Founded
2002
ISIN
KR8840090003
FIGI
BBG004FMF955
Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, immunochemical diagnosis, biosensor, and molecular diagnostic technology. Its products are diagnostic reagents that diagnose infectious diseases such as malaria, influenza, and Coronavirus. The company was founded on September 27, 2002 and is headquartered in Somerset, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 950130.